LMAT (LeMaitre Vascular) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMAT LeMaitre Vascular Inc LMAT
100 GF Score
Price $81.45
GF Value $95.27
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


LeMaitre Vascular  (NAS:LMAT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


LeMaitre Vascular Cyclically Adjusted PB Ratio Related Terms


LeMaitre Vascular Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for LeMaitre Vascular's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Cyclically Adjusted PB Ratio Chart

LeMaitre Vascular Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.04 6.21 6.70 9.54 7.37

LeMaitre Vascular Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.99 8.15 7.37 9.49 8.04

LMAT vs PLSE, XRAY, ATRC: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Cyclically Adjusted PB Ratio falls into.


LMAT
100GF Score
LeMaitre Vascular Inc LMAT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeMaitre Vascular Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

LeMaitre Vascular's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, LeMaitre Vascular's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=17.135/333.9520*333.9520
=17.135

Current CPI (Jun. 2026) = 333.9520.

LeMaitre Vascular Quarterly Data

Book Value per Share CPI Adj_Book
201609 4.666 241.428 6.454
201612 4.707 241.432 6.511
201703 4.899 243.801 6.711
201706 5.200 244.955 7.089
201709 5.509 246.819 7.454
201712 5.698 246.524 7.719
201803 5.879 249.554 7.867
201806 6.238 251.989 8.267
201809 6.401 252.439 8.468
201812 6.642 251.233 8.829
201903 6.766 254.202 8.889
201906 6.965 256.143 9.081
201909 7.123 256.759 9.264
201912 7.349 256.974 9.550
202003 7.376 258.115 9.543
202006 7.563 257.797 9.797
202009 7.934 260.280 10.180
202012 8.409 260.474 10.781
202103 8.621 264.877 10.869
202106 8.994 271.696 11.055
202109 11.404 274.310 13.884
202112 11.593 278.802 13.886
202203 11.743 287.504 13.640
202206 11.749 296.311 13.241
202209 11.874 296.808 13.360
202212 12.143 296.797 13.663
202303 12.382 301.836 13.699
202306 12.749 305.109 13.954
202309 12.965 307.789 14.067
202312 13.343 306.746 14.526
202403 13.744 312.332 14.695
202406 14.221 314.175 15.116
202409 14.726 315.301 15.597
202412 14.958 315.605 15.828
202503 15.383 319.799 16.064
202506 16.022 322.561 16.588
202509 16.706 324.800 17.177
202512 17.280 324.054 17.808
202603 17.797 330.213 17.999
202606 17.135 333.952 17.135

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is LeMaitre Vascular (LMAT) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.27. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for LMAT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $95.27 vs. price of $81.45 (14.5% below fair value)
  • GF Score™: 100/100

No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeMaitre Vascular Business Description

Other Exchanges LHU:Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score

Get the complete analysis for LMAT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.45
Price
$95.27
GF Value